Skip to main content
. Author manuscript; available in PMC: 2009 Oct 6.
Published in final edited form as: Biochem Pharmacol. 2007 Oct 16;75(4):907–913. doi: 10.1016/j.bcp.2007.10.010

Fig. 2.

Fig. 2

(A–F). Statins differ in their ability to suppress NF-κB activation in KBM-5 cells. KBM-5 cells (1 × 106/mL) were preincubated with the indicated concentrations of statins for 12 hours at 37°C and then treated with 0.1 nM TNF for 30 minutes. Nuclear extracts were prepared and tested for NF-κB activation as described in Materials and Methods. (G). Quantitative analysis of NF-κB inhibitory effect of different statins.